Indivior PLC | Cash Flow

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
444,630.90
341,318.20
226,468.90
110,427.60
149,865.40
218,988.30
Depreciation, Depletion & Amortization
17,913.20
15,790.50
20,945.10
10,375.80
10,094.60
11,999.40
Other Funds
-
211,957.40
-
-
-
25,498.60
Funds from Operations
420,320.20
298,805.30
126,325.10
51,137.60
119,581.70
205,489
Changes in Working Capital
85,727.40
31,581.00
83,125.90
250,500.30
109,487.20
21,748.80
Net Operating Cash Flow
506,047.60
267,224.20
209,451.00
301,637.90
229,068.90
227,237.90
Capital Expenditures
1,919.30
15,790.50
20,290.60
25,939.40
33,389.70
Net Investing Cash Flow
1,919.30
15,790.50
20,290.60
25,939.40
33,389.70
Cash Dividends Paid - Total
-
303,663.90
15,054.30
51,137.60
-
Issuance/Reduction of Debt, Net
-
460,961.80
79,198.70
57,807.80
66,779.40
Net Financing Cash Flow
515,643.90
54,659.50
94,253.00
108,945.40
65,226.40
Net Change in Cash
11,515.60
196,774.20
89,016.70
166,753.10
132,782.30
Free Cash Flow
504,128.30
267,224.20
191,778.60
286,815.40
205,773.80
Change in Capital Stock
515,643.90
-
-
-
1,553.00
Exchange Rate Effect
-
-
5,890.80
-
2,329.50

About Indivior

View Profile
Address
103-105 Bath Road
Slough Berkshire SL1 3UH
United Kingdom
Employees -
Website http://indivior.com/
Updated 07/08/2019
Indivior PLC is a holding company, which engages in the manufacture and distribution of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, Subutex Tablet, and Sublocade Injection. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.